Literature DB >> 20010496

Effectiveness of photodynamic therapy in the treatment of lichen sclerosus: cell changes in immunohistochemistry.

Anita Olejek1, Iwona Kozak-Darmas, Sylwia Kellas-Sleczka, Katarzyna Steplewska, Tomasz Biniszkiewicz, Beata Birkner, Anna Jarek, Leszek Nowak, Krystyna Stencel-Gabriel, Aleksander Sieron.   

Abstract

BACKGROUND: Vulvar lichen sclerosus (LS) affects primarily women at postmenopausal age and its background remains unknown. One of the treatment modalities is photodynamic therapy (PDT). The aim was to investigate the efficacy of PDT in women with LS and the analysis of protein expression before and after PDT.
MATERIAL AND METHODS: From 04.2006-01.2008 28 women, with LS underwent photodynamic diagnosis and next PDT: six-courses every second week with using 5-aminolevulinic acid (ALA) as a photosensitizer. Punch biopsies were taken before and after treatment and immunohistochemistry was done with Ki67,CD44,CD34 and CD3.
RESULTS: Before PDT all patients suffered from pruritus and after in 89.3% the relief was noted. The histological examination showed that 35.7% patients hadn't LS after therapy completion. Anti-CD44 staining intensities was scored qualitatively - there were no statistical difference at the expression of protein CD44 in the epidermis (p>0.05) before and after therapy. Microvessel density was assessed at the hot spots, marked with anti-CD34. Statistical difference in AVD before and after therapy: (p<0.05). The staining intensity of Ki-67 didn't differ before and after PDT (p>0.05). The expression of CD3 on T lymphocytes showed statistical difference of the lymphocytic infiltration before and after PDT ( p<0.05).
CONCLUSION: The immunohistochemical staining in vulvar LS showed increasing microvessel density and decreasing lymphocytic infiltration. There were a clinical, and less histological improvement in patients with LS. We suggest that the photodynamic therapy is an effective, alternative treatment in some but not all patients with LS. Therefore, further studies are needed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20010496

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  5 in total

Review 1.  [Lichen sclerosus in the genitourinary region].

Authors:  C Hofer; F-M Köhn; G S Hatzichristodoulou; J E Gschwend; U Treiber
Journal:  Urologe A       Date:  2011-10       Impact factor: 0.639

2.  5-Aminolevulinic acid photodynamic therapy in refractory vulvar lichen sclerosus et atrophicus: Series of ten cases.

Authors:  Ting Lan; Yongzhen Zou; Michael R Hamblin; Rui Yin
Journal:  Photodiagnosis Photodyn Ther       Date:  2017-12-16       Impact factor: 3.631

3.  The Immunogenetic Aspects of Photodynamic Therapy.

Authors:  Chaw-Ning Lee; Tak-Wah Wong
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Use of Platelet-rich Plasma for Vulvovaginal Autoimmune Conditions Like Lichen Sclerosus.

Authors:  Fariba Behnia-Willison; Nina Reza Pour; Behrang Mohamadi; Nadia Willison; Madeleine Rock; Ian W Holten; Robert O'Shea; Joseph Miller
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-11-23

Review 5.  Diagnosis and treatment of lichen sclerosus: an update.

Authors:  Susanna K Fistarol; Peter H Itin
Journal:  Am J Clin Dermatol       Date:  2013-02       Impact factor: 7.403

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.